ConductScience.org, home

Paper24678938

Renal denervation for resistant hypertension?

Messerli FH and 1 other. N Engl J Med, 2014. Cited by 56 papers, by iCite.

Cite this record

ConductScience Library. Renal denervation for resistant hypertension? Papers, record 24678938. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24678938

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Renal denervation for resistant hypertension?
PubMed
Journal
N Engl J Med
PubMed
Year
2014
PubMed
Publication types
Editorial, Comment
PubMed
Citations, by iCite
56
iCite
Relative citation ratio, by iCite
1.76
iCite
Revised in PubMed
2022-03-17
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Messerli FHFranz H
2Bangalore SSripal

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DenervationMajor topic
HypertensionMajor topic
Renal ArteryMajor topic
Female
Humans
Male

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment on24678939A controlled trial of renal denervation for resistant hypertension.https://conductscience.org/library/papers/24678939

Source PubMed

Download CSV of comments and corrections

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.

PMIDTitleJournalYearIn PapersSource
37559838The Implementation of Renal Denervation in the Management of Resistant Hypertension Despite Use of Multitherapy Antihypertensives at Maximally Tolerated Doses: A Contemporary Literature Review.Cureus2023https://conductscience.org/library/papers/37559838PubMed
32510250Device profile of the MobiusHD EVBA system for the treatment of resistant hypertension: overview of its mechanism of action, safety and efficacy.Expert Rev Med Devices2020https://conductscience.org/library/papers/32510250PubMed
31746943Renal denervation: dark past, bright future?Cardiovasc J Afr2019https://conductscience.org/library/papers/31746943PubMed
31205656British Society of Gastroenterology Endoscopy Quality Improvement Programme (BSG EQIP): Implementing new endoscopic techniques and technologies into clinical practice.Frontline Gastroenterol2019https://conductscience.org/library/papers/31205656PubMed
30203149Catheter-Based Renal Denervation for Hypertension.Curr Hypertens Rep2018https://conductscience.org/library/papers/30203149PubMed
29657937The Role of Angiotensin II Infusion on the Baroreflex Sensitivity and Renal Function in Intact and Bilateral Renal Denervation Rats.Adv Biomed Res2018https://conductscience.org/library/papers/29657937PubMed
28935036Inferior Vena Cava Filters to Prevent Pulmonary Embolism: Systematic Review and Meta-Analysis.J Am Coll Cardiol2017https://conductscience.org/library/papers/28935036PubMed
28405824Redo renal denervation using a multi-electrode radiofrequency system in patients with persistent therapy-resistant hypertension.Neth Heart J2017https://conductscience.org/library/papers/28405824PubMed
28338768Integrative Blood Pressure Response to Upright Tilt Post Renal Denervation.Am J Hypertens2017https://conductscience.org/library/papers/28338768PubMed
27838622Catheter-Based Renal Denervation for Resistant Hypertension: Will It Ever Be Ready for "Prime Time"?Am J Hypertens2017https://conductscience.org/library/papers/27838622PubMed
27245681Renal Denervation: a Field in Flux.Curr Hypertens Rep2016https://conductscience.org/library/papers/27245681PubMed
26619813Renal Denervation vs Pharmacotherapy for Resistant Hypertension: A Meta-Analysis.J Clin Hypertens (Greenwich)2016https://conductscience.org/library/papers/26619813PubMed
25759273Renal denervation for severe hypertension in a small child with Turner syndrome: miniaturisation of the procedure and results.BMJ Case Rep2015https://conductscience.org/library/papers/25759273PubMed
25332808Renal denervation and blood pressure reduction in resistant hypertension: a systematic review and meta-analysis.Open Heart2014https://conductscience.org/library/papers/25332808PubMed
25326400Where and when device therapy may be useful in the management of drug-resistant hypertension.Curr Cardiol Rep2014https://conductscience.org/library/papers/25326400PubMed
25304105The future of renal denervation in resistant hypertension.Curr Hypertens Rep2014https://conductscience.org/library/papers/25304105PubMed
25300359Renal denervation therapy for resistant hypertension.Curr Treat Options Cardiovasc Med2014https://conductscience.org/library/papers/25300359PubMed
25169179Translating stem cell research to cardiac disease therapies: pitfalls and prospects for improvement.J Am Coll Cardiol2014https://conductscience.org/library/papers/25169179PubMed
25135921Assessment and management of resistant hypertension.CMAJ2014https://conductscience.org/library/papers/25135921PubMed
25061451Renal denervation after the symplicity HTN-3 trial.Postepy Kardiol Interwencyjnej2014https://conductscience.org/library/papers/25061451PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24678938

GET https://conductscience.org/api/papers/v1/24678938/cited_by?page=2